U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Retinal telangiectasia

MedGen UID:
57598
Concept ID:
C0154835
Disease or Syndrome
Synonym: Telangiectasia of the retina
SNOMED CT: Retinal grouped capillary aneurysms (84884003); Retinal telangiectasia (84884003)
 
HPO: HP:0007763
Monarch Initiative: MONDO:0004348

Definition

Dilatation of small blood vessels of the retina. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRetinal telangiectasia

Conditions with this feature

Exudative retinopathy
MedGen UID:
102319
Concept ID:
C0154832
Disease or Syndrome
Coats disease (CD) is an idiopathic disorder characterized by retinal telangiectasia with deposition of intraretinal or subretinal exudates, potentially leading to retinal detachment and unilateral blindness. CD is classically an isolated and unilateral condition affecting otherwise healthy young children.
Retinal telangiectasia and hypogammaglobulinemia
MedGen UID:
419680
Concept ID:
C2930961
Disease or Syndrome
Cerebroretinal microangiopathy with calcifications and cysts 2
MedGen UID:
1390862
Concept ID:
C4479220
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
Cerebroretinal microangiopathy with calcifications and cysts 1
MedGen UID:
1636142
Concept ID:
C4552029
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
Facioscapulohumeral muscular dystrophy 1
MedGen UID:
1727901
Concept ID:
C5399970
Disease or Syndrome
Facioscapulohumeral muscular dystrophy (FSHD) typically presents with weakness of the facial muscles, the stabilizers of the scapula, or the dorsiflexors of the foot. Severity is highly variable. Weakness is slowly progressive and approximately 20% of affected individuals eventually require a wheelchair. Life expectancy is not shortened.
Leber hereditary optic neuropathy, autosomal recessive
MedGen UID:
1786310
Concept ID:
C5543589
Disease or Syndrome
Rabin-Pappas syndrome
MedGen UID:
1824042
Concept ID:
C5774269
Disease or Syndrome
Rabin-Pappas syndrome (RAPAS) is a multisystemic disorder characterized by severely impaired global development apparent from infancy, feeding difficulties with failure to thrive, small head circumference, and dysmorphic facial features. Affected individuals have impaired intellectual development and hypotonia; they do not achieve walking or meaningful speech. Other neurologic findings may include seizures, hearing loss, ophthalmologic defects, and brain imaging abnormalities. There is variable involvement of other organ systems, including skeletal, genitourinary, cardiac, and possibly endocrine (Rabin et al., 2020).
Intellectual developmental disorder, autosomal dominant 70
MedGen UID:
1824044
Concept ID:
C5774271
Disease or Syndrome
Autosomal dominant intellectual developmental disorder-70 (MRD70) is characterized by mild global developmental delay, moderately impaired intellectual disability with speech difficulties, and behavioral abnormalities. More variable findings may include hypotonia and dysmorphic features (Rabin et al., 2020)

Professional guidelines

PubMed

Sen M, Shields CL, Honavar SG, Shields JA
Indian J Ophthalmol 2019 Jun;67(6):763-771. doi: 10.4103/ijo.IJO_841_19. PMID: 31124484Free PMC Article
Bonfiglio V, Reibaldi M, Fallico M, Russo A, Pizzo A, Fichera S, Rapisarda C, Macchi I, Avitabile T, Longo A
Drug Des Devel Ther 2017;11:2359-2372. Epub 2017 Aug 16 doi: 10.2147/DDDT.S138922. PMID: 28860707Free PMC Article
Mulvihill A, Morris B
Eye (Lond) 2010 Dec;24(12):1802-7. Epub 2010 Sep 24 doi: 10.1038/eye.2010.127. PMID: 20865028

Recent clinical studies

Etiology

Banerjee M, Nayak S, Kumar S, Bhayana AA, Kumar V
Surv Ophthalmol 2023 Jul-Aug;68(4):591-600. Epub 2023 Mar 17 doi: 10.1016/j.survophthal.2023.03.002. PMID: 36933772
Hess K, Park YJ, Kim HA, Holz FG, Charbel Issa P, Yoon YH, Tzaridis S
Ophthalmol Retina 2023 Feb;7(2):101-110. Epub 2022 Aug 7 doi: 10.1016/j.oret.2022.08.004. PMID: 35948211
Hess K, Charbel Issa P, Holz FG, Tzaridis S
Br J Ophthalmol 2022 Dec;106(12):1736-1741. Epub 2021 Jun 24 doi: 10.1136/bjophthalmol-2020-318470. PMID: 34167944
Breazzano MP, Yannuzzi LA, Spaide RF
Retina 2021 Mar 1;41(3):464-470. doi: 10.1097/IAE.0000000000002986. PMID: 32976212
Krivosic V, Lavia C, Aubineau A, Tadayoni R, Gaudric A
Ophthalmol Retina 2021 Jun;5(6):562-570. Epub 2020 Sep 19 doi: 10.1016/j.oret.2020.09.012. PMID: 32956858

Diagnosis

Daruich A, Munier FL
BMJ Open Ophthalmol 2022;7(1):e000883. Epub 2022 Feb 4 doi: 10.1136/bmjophth-2021-000883. PMID: 35141419Free PMC Article
Ledolter AA, Ristl R, Palmowski-Wolfe AM, Montuoro A, Deak GG, Sacu S, Holder GE, Schmidt-Erfurth U, Ritter M
Acta Ophthalmol 2022 Sep;100(6):e1240-e1252. Epub 2021 Dec 1 doi: 10.1111/aos.15072. PMID: 34854225
Ruben M, Yaghy A, Park CH, Shields CL
J Pediatr Ophthalmol Strabismus 2020 Oct 20;57:e82-e85. doi: 10.3928/01913913-20200818-01. PMID: 33090232
Sen M, Shields CL, Honavar SG, Shields JA
Indian J Ophthalmol 2019 Jun;67(6):763-771. doi: 10.4103/ijo.IJO_841_19. PMID: 31124484Free PMC Article
Rabb MF, Gagliano DA, Teske MP
Surv Ophthalmol 1988 Sep-Oct;33(2):73-96. doi: 10.1016/0039-6257(88)90160-9. PMID: 3055391

Therapy

Hess K, Park YJ, Kim HA, Holz FG, Charbel Issa P, Yoon YH, Tzaridis S
Ophthalmol Retina 2023 Feb;7(2):101-110. Epub 2022 Aug 7 doi: 10.1016/j.oret.2022.08.004. PMID: 35948211
Loo J, Cai CX, Choong J, Chew EY, Friedlander M, Jaffe GJ, Farsiu S
Br J Ophthalmol 2022 Mar;106(3):396-402. Epub 2020 Nov 23 doi: 10.1136/bjophthalmol-2020-317131. PMID: 33229343Free PMC Article
Lavinsky D, Silva MOD, Chaves AE, Schneider WFM, Lavinsky F, Palanker D
Retina 2021 Mar 1;41(3):487-494. doi: 10.1097/IAE.0000000000002882. PMID: 33370517
Bonfiglio V, Reibaldi M, Fallico M, Russo A, Pizzo A, Fichera S, Rapisarda C, Macchi I, Avitabile T, Longo A
Drug Des Devel Ther 2017;11:2359-2372. Epub 2017 Aug 16 doi: 10.2147/DDDT.S138922. PMID: 28860707Free PMC Article
Rabb MF, Gagliano DA, Teske MP
Surv Ophthalmol 1988 Sep-Oct;33(2):73-96. doi: 10.1016/0039-6257(88)90160-9. PMID: 3055391

Prognosis

Breazzano MP, Yannuzzi LA, Spaide RF
Retina 2021 Mar 1;41(3):464-470. doi: 10.1097/IAE.0000000000002986. PMID: 32976212
Ruben M, Yaghy A, Park CH, Shields CL
J Pediatr Ophthalmol Strabismus 2020 Oct 20;57:e82-e85. doi: 10.3928/01913913-20200818-01. PMID: 33090232
Bonfiglio V, Reibaldi M, Fallico M, Russo A, Pizzo A, Fichera S, Rapisarda C, Macchi I, Avitabile T, Longo A
Drug Des Devel Ther 2017;11:2359-2372. Epub 2017 Aug 16 doi: 10.2147/DDDT.S138922. PMID: 28860707Free PMC Article
Wu L, Evans T, Arevalo JF
Surv Ophthalmol 2013 Nov-Dec;58(6):536-59. doi: 10.1016/j.survophthal.2012.11.007. PMID: 24160729
Khan JA, Ide CH, Strickland MP
Surv Ophthalmol 1988 Mar-Apr;32(5):317-32. doi: 10.1016/0039-6257(88)90094-x. PMID: 2457260

Clinical prediction guides

Hess K, Park YJ, Kim HA, Holz FG, Charbel Issa P, Yoon YH, Tzaridis S
Ophthalmol Retina 2023 Feb;7(2):101-110. Epub 2022 Aug 7 doi: 10.1016/j.oret.2022.08.004. PMID: 35948211
Ledolter AA, Ristl R, Palmowski-Wolfe AM, Montuoro A, Deak GG, Sacu S, Holder GE, Schmidt-Erfurth U, Ritter M
Acta Ophthalmol 2022 Sep;100(6):e1240-e1252. Epub 2021 Dec 1 doi: 10.1111/aos.15072. PMID: 34854225
Hess K, Charbel Issa P, Holz FG, Tzaridis S
Br J Ophthalmol 2022 Dec;106(12):1736-1741. Epub 2021 Jun 24 doi: 10.1136/bjophthalmol-2020-318470. PMID: 34167944
Loo J, Cai CX, Choong J, Chew EY, Friedlander M, Jaffe GJ, Farsiu S
Br J Ophthalmol 2022 Mar;106(3):396-402. Epub 2020 Nov 23 doi: 10.1136/bjophthalmol-2020-317131. PMID: 33229343Free PMC Article
Krivosic V, Lavia C, Aubineau A, Tadayoni R, Gaudric A
Ophthalmol Retina 2021 Jun;5(6):562-570. Epub 2020 Sep 19 doi: 10.1016/j.oret.2020.09.012. PMID: 32956858

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...